Effect of different doses of sufentanil on anesthesia introduction in pediatric squint surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048747

Enrollment

Unknown

Registered

2021-07-15

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

strabismus

Interventions

S1 group:sufentanil 0.2ug/kg

S2 group:sufentanil 0.3ug/kg

S3 group:sufentanil 0.5ug/kg

Eligibility

Sex/Gender

All

Age

1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1-12 years old, ASAI-II grade; 2. Elective pediatric strabismus surgery; 3. The operation time is 30min~1h; 4. BMI 18.5~23.9; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Abnormal liver and kidney function; 3. Severe dehydration and severe malnutrition or Hb =23.9; 5. Children with neurological diseases; 6. History of hypersensitivity to study drug.

Design outcomes

Primary

Measure	Time frame
Intraoperative vital signs;Intraoperative complications and medication;	—

Secondary

Measure	Time frame
Postoperative agitation score;Postoperative pain score;	—

Countries

China

Contacts

Public ContactXu Aijun

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of science and technology

ajxu@tjh.tjmu.edu.cn+86 27 83663173

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026